** Shares of Mach7 Technologies M7T.AX extend gains from the previous session to climb 8% to A$0.4

** Stock hits highest level since Nov 5, 2024

** The medical imaging systems provider posts contracted annual recurring revenue $(CARR)$ of A$31.8 mln ($19.76 mln) at Dec 31, up 15.6% from Sept 2024 levels

** Co reaffirms FY25 outlook for 15-25% growth in CARR

** Co announced on-market buyback programme of up to A$5 mln on Thursday

** About 1.1 mln shares change hands, 2.5 times the 30-day average of share

** Stock down 7.5% this year, as of last close

($1 = 1.6095 Australian dollars)

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com;))